- Labguru and Titian Software Rebrand as Cenevo
- Aptitude Awarded a BARDA Contract Modification to Add Avian Flu Detection to the Metrix® Platform
- TA Invests in HealthMark Group to Support the Next Phase of Growth
- New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease | Presented at the 2025 Alzheimer’s Association International Conference
- AI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan Platforms
- Vektor Medical Reports | vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care
- AngioDynamics Announces Publication of PRESERVE Study of NanoKnife System for Prostate Tissue Ablation in European Urology
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
NEC Corporation Has Developed Technologies that Enable a Secure Workflow for Personalized Cancer Vaccines & Has Proven their Capabilities
This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies
CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
The poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) in Chicago on March 30, 2025.
MedCognition Announces Extended Reality (XR) Medical Simulation Training Technology Receives Broad Method Patent from USPTO
Integrated within the company’s PerSim® medical education and training platform, the patented XR-based technology increases training efficacy by providing a safe and controlled environment that closely resembles authentic patient encounters, allowing students to refine their clinical skills and improve preparedness through real-world scenario simulations.
Myant Launches Care360: AI-Powered Precision Cardiac Assessments Delivered Directly to Patients and Physicians
“There has been far too little effort to raise awareness about atrial fibrillation—the most common arrhythmia and a leading driver of stroke, heart failure, and mortality,” said Dr. Yaariv Khaykin, Chief Medical Officer of Myant. “Atrial Fibrillation leads to impaired quality of life and affects productivity, yet many patients don’t even realize they have it. Some experience palpitations, others just feel fatigued and attribute it to aging. Many physicians remain unaware of innovations in Atrial Fibrillation management that could transform care. Myant Care360, with direct Atrial Fibrillation assessment referrals, provides unprecedented access to specialized care and early intervention—strategies that have been shown in randomized studies to slow or even reverse the progression of Atrial Fibrillation.”
Clinical Trials
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
Nicolas Poirier, Chief Executive Officer of OSE Immunotherapeutics, concludes: “We are very pleased with this publication on Lusvertikimab in ‘Blood’, a high-level journal within the field of hematology whose manuscripts are reviewed by prominent specialists. Novel targeted immunotherapy options are urgently needed for B-ALL and T-ALL patients and we are happy to collaborate with the research leaders in hematology from the University of Kiel to face this clinical challenge.”
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera
“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases that can impact patients’ quality of life and lead to life-threatening complications, including the development of specific types of blood cancers, and PharmaEssentia is committed to developing new therapeutic solutions for these patients,” said Robert B. Geller, M.D., Head of Medical at PharmaEssentia USA. “We are thrilled with the pace at which we have enrolled patients, which we believe reflects a high level of interest in both the EXCEED-ET and ECLIPSE-PV trials. Our goal with each of these programs is to redefine the early treatment paradigm of myeloproliferative neoplasms.”
Dr Fred Cohen: Higher Temperatures Trigger Migraines According to New Study
In the study, researchers examined 71,030 daily diary records from 660 migraine patients and correlated them with regional weather data. They discovered that for each 10-degree Fahrenheit rise in daily temperature, there was a 6% increase in headache occurrences reports Dr Fred Cohen.
Biotechnology News
Lonza Launches Innovaform™ Accelerator, the New Innovation and Formulation Center in Colmar (FR)
Christian Seufert, President, Capsules & Health Ingredients, Lonza, commented: “The Innovaform™ Innovation and Formulation Accelerator represents a unique solution for drug developers seeking to solve complex dosage form and delivery challenges through innovation.
NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases
Under the terms of the agreement, Novo Nordisk and NanoVation Therapeutics will collaborate on two lead programs to develop base-editing therapies for certain rare genetic diseases, and up to five additional future targets for cardiometabolic and rare diseases.
Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
MindLight is the first circular RNA biomarker-based assay designed to predict whether a patient with depression, also known as major depressive disorder, will respond to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Tevogen Bio Announces $8 Million Equity Investment
“We are excited to begin our journey as a public company with this additional investment. We believe Tevogen’s patient-centric approach, which merges a focus on affordability with advanced science, is a blueprint for sustainable success in the current era of healthcare. I am pleased that investors now have the opportunity to participate in Tevogen’s mission to become the very first life science company offering commercially attractive and affordable personalized T cell therapies for large patient populations in virology, oncology, and neurology, said the CEO of Tevogen Bio.
MB2 Dental Raises US$2.344bn Unitranche Debt Facility With KKR
MB2 Dental notes the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.
Procyrion Closes $57.7 Million in Series E Financing
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company’s Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
PhotoniCare Achieves More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology
PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.
Market Reports
Advancements in Imaging
Nesa Medtech Receives FDA Clearance for Its Fibroid Mapping Reviewer Application
Nesa Medtech advises their novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
KA Imaging To Launch Premium Dual-Energy Mobile System at AHRA
“This partnership with Del Medical comes at an excellent time,” said Amol Karnick, President and CEO of KA Imaging. “After the pandemic, mobile imaging has become more prominent in many healthcare facilities, so offering a solution to improve the visualization of bones and tissues at the bedside is essential,” said Karnick.
Lunit Makes Full-Fledged Entry into the Middle East with Participation in ‘Saudi Vision 2030’ Healthcare Transformation Project
The partnership seeks to contribute to driving healthcare transformation across Saudi Arabia, aligning with the Kingdom’s ‘Saudi Vision 2030’ strategy.
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
What Are the Top Skills Every Future Doctor Needs to Perfect?
From the delicate art of suturing to mastering advanced communication, in this article we’ll explore the multifaceted world of modern medicine.
How Can Online Exam Software Improve CPR Training and Certification?
As more and more human beings opt for guides on CPR education, the need for this education becomes increasingly critical.
Systematic Education for Sedation: A Guide for Hospital Leaders
This guide provides comprehensive recommendations for implementing effective systematic education for sedation for healthcare professionals. Read on to learn more.
The Importance of Employee Development Plans for Your Company and Staff
In today’s business environment, it has become crucial for organizations to prioritize employee development plans as a means to foster growth and drive success. It’s
Healthcare Careers
Nurses Corner
All About Adult-Gerontology Acute Care Nursing
Acute care is the timely administration of short-term care in cases of serious illness, injury, aggravated chronic conditions, or other health conditions, such as recovery
4 Ways Nurses Can Ease Patient Anxiety
It’s very common for people to experience severe anxiety whenever they are in a hospital, and rightfully so. If a person gets admitted to the
6 Benefits of Becoming an Aesthetic Nurse
As a nurse, you are concerned about the patient’s physical requirements. You lean over graphs filled with blood sugar and biochemical panel results far too